A Phase III, Multicentre, Single-arm, Open-label Study to Evaluate the Long-term Safety of Z-338 in Subjects With Functional Dyspepsia
Phase of Trial: Phase III
Latest Information Update: 30 Jun 2017
At a glance
- Drugs Acotiamide (Primary)
- Indications Non-ulcer dyspepsia
- Focus Adverse reactions; Registrational
- Sponsors Zeria
- 27 Jun 2017 Status changed from active, no longer recruiting to completed.
- 26 Mar 2017 This trial has been completed in the United Kingdom (end date: 30 Sep 2016).
- 23 Oct 2016 This trial has been completed in Bulgaria (end date: 2016-09-30), according to European Clinical Trials Database.